2007
DOI: 10.1002/cmdc.200700013
|View full text |Cite
|
Sign up to set email alerts
|

Model Systems for Activation of Nucleic Acid Encoded Prodrugs

Abstract: The development of more selective chemotherapeutic agents for benign treatments of malicious diseases is highly desirable. In recent years model systems for the release of small molecule drugs from nucleic acid conjugates by templated chemical or photochemical reactions have been designed. Common for these systems is that the stoichiometric or catalytic drug release is controlled by the highly selective hybridization between complementary strands of nucleic acids. Herein, the concepts of the new field of nucle… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
21
0
3

Year Published

2008
2008
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(24 citation statements)
references
References 55 publications
0
21
0
3
Order By: Relevance
“…The broad toolkit of programmable oligomeric structures makes DNA and RNA invaluable scaffolds. [44] Colocalization of enzymes in a metabolic pathway can improve reaction efficiency by increasing the effective molarity of intermediate (see section 2, above) and, if the proteins are close enough, intermediate transfer is even more efficient as diffusion is dimensionally restricted along the protein hydration shells. [45] …”
Section: Dna/rna Templated Reactionsmentioning
confidence: 99%
“…The broad toolkit of programmable oligomeric structures makes DNA and RNA invaluable scaffolds. [44] Colocalization of enzymes in a metabolic pathway can improve reaction efficiency by increasing the effective molarity of intermediate (see section 2, above) and, if the proteins are close enough, intermediate transfer is even more efficient as diffusion is dimensionally restricted along the protein hydration shells. [45] …”
Section: Dna/rna Templated Reactionsmentioning
confidence: 99%
“…Diese Nukleinsäure-kodierte Information könnte genutzt werden, um molekulare Therapien selektiv auf erkrankte Zellen oder Gewebe zu richten. Ein interessanter Ansatz würde krankheitsspezifische Nukleinsäuresequenzen dazu nutzen, die Bildung oder Freisetzung von Wirkstoffmolekülen auszulö-sen. [1] Kürzlich wurde gezeigt, dass Hybridisierungsprozesse von Nukleinsäuren die Freisetzung von Modellwirkstoffen wie pNitrophenol und Cumarin, [2] Biotin oder Benzoesäure [3] steuern können. Gothelf, Mokhir et al führten die DNASteuerung der Bildung von Singulettsauerstoff durch Pyropheophorbid ein.…”
unclassified
“…Bioorthogonal reactions catalyzed by spatial proximity and photoinduction can be used to trigger the release of prodrugs upon interaction with unique or overexpressed RNA or DNA sequences. Winssinger and co‐workers developed a para ‐azidobenzyl‐based immolative linker for the uncaging of functional molecules (Figure a).…”
Section: In Situ Protein Interferencementioning
confidence: 99%